Walleye Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Buy |
35,290
+23,343
| +195% | +$213K | ﹤0.01% | 1221 |
|
|
2025
Q1 | $95K | Sell |
11,947
-44,126
| -79% | -$351K | ﹤0.01% | 1552 |
|
|
2024
Q4 | $304K | Sell |
56,073
-164,900
| -75% | -$895K | ﹤0.01% | 1358 |
|
|
2024
Q3 | $1.6M | Buy |
220,973
+92,229
| +72% | +$666K | ﹤0.01% | 872 |
|
|
2024
Q2 | $1.4M | Buy |
128,744
+62,428
| +94% | +$678K | ﹤0.01% | 973 |
|
|
2024
Q1 | $1.24M | Sell |
66,316
-3,443
| -5% | -$64.5K | ﹤0.01% | 953 |
|
|
2023
Q4 | $1.51M | Buy |
+69,759
| New | +$1.51M | ﹤0.01% | 737 |
|
|
2023
Q3 | – | Sell |
-54,561
| Closed | -$2.57M | – | 2872 |
|
|
2023
Q2 | $2.57M | Buy |
+54,561
| New | +$2.57M | 0.01% | 453 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2627 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2551 |
|
|
2022
Q3 | – | Sell |
-33,199
| Closed | -$1.07M | – | 2679 |
|
|
2022
Q2 | $1.07M | Buy |
+33,199
| New | +$1.07M | 0.03% | 601 |
|
|
2022
Q1 | – | Sell |
-75,679
| Closed | -$3.22M | – | 2489 |
|
|
2021
Q4 | $3.22M | Buy |
+75,679
| New | +$3.22M | 0.1% | 219 |
|
|
2020
Q2 | – | Sell |
-18,445
| Closed | -$530K | – | 762 |
|
|
2020
Q1 | $530K | Buy |
+18,445
| New | +$530K | 0.12% | 154 |
|
|
2019
Q4 | – | Sell |
-9,199
| Closed | -$1.29M | – | 1018 |
|
|
2019
Q3 | $1.29M | Buy |
+9,199
| New | +$1.29M | 0.08% | 27 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 836 |
|